ARS Pharmaceuticals cuts 2026 expenses after no new neffy coverage gains

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/29/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to ARS Pharmaceuticals cuts 2026 expenses after no new neffy coverage gains
(NASDAQ: SPRY) Delayed: 5.89 -0.14 (2.32%)
Previous Close $6.03    52 Week High $ 
Open $6.00    52 Week Low $ 
Day High $6.03    P/E N/A 
Day Low $5.86    EPS $ 
Volume 1,190,266